Smart Inhalers Market Size To Reach $53.3 Billion By 2030

Smart Inhalers Market Growth & Trends

The global smart inhalers market size is expected to reach USD 53.3 billion by 2030 and is projected to grow at a CAGR of 19.4% from 2024 to 2030, according to a new report by Grand View Research, Inc.  The growth of the smart inhaler market is driven by several key factors, including the rising prevalence of respiratory diseases, increased awareness initiatives, the integration of digital technologies in medical devices, and the development of advanced products by market players. The global rise in chronic respiratory diseases, exacerbated by pollution and low immunity, particularly asthma and COPD, fuels demand for inhalers. According to the American Lung Association, approximately 11.7 million people in the U.S., or 4.6% of adults, were diagnosed with COPD in 2022, which is expected to boost demand for technologically advanced inhalers.

Smart inhalers offer benefits over traditional ones, such as dosage reminders, health tracking, adherence support, and data-driven insights. Market players are actively investing in innovative solutions to meet evolving demands. For example, Aptar Pharma introduced HeroTracker Sense in April 2022, transforming conventional inhalers into smart devices, and partnered with Lupin Limited in January 2020 to launch the ADHERO device, which tracks medication usage via the “MyAdhero” application. These advancements are anticipated to drive global demand for smart inhalers.

In addition, government and private sector initiatives are enhancing awareness about respiratory diseases. The American Lung Association’s “Addressing COPD” project, launched in November 2022, aims to improve the care of 12.5 million COPD patients in the U.S. Such efforts, combined with the growing availability of advanced devices, significantly contribute to the smart inhaler market’s growth.

 Request a free sample copy or view report summary: Smart Inhalers Market Report

Smart Inhalers Market Report Highlights

• Based on type, the market is segmented into dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). The MDI segment held the largest revenue share of 64.0% in 2023 and is anticipated to witness fastest growth from 2024 to 2030. This is attributable to their increasing popularity as they are easy to use in fixed-dose short bursts sprays

• Based on indication, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), and others. The COPD segment dominated the market with a revenue share of 50.7% in 2023, owing to the high prevalence of COPD globally and increasing awareness about this disease. Moreover, the other segment is anticipated to showcase the fastest growth of CAGR 21.8% over the forecast period

• Based on distribution channel, the market is segmented into hospital, retail, and online pharmacies. The hospital pharmacies segment held the largest revenue share of 44.3% in 2023. Hospital pharmacies offer better flexibility, comfort, and convenience for purchasing smart inhalers for hospitalized patients. In addition, the online pharmacies segment is expected to grow at the fastest CAGR of 22.1% over the forecast period

• Based on end use, the market is segmented into hospitals, home care settings, and others. The hospitals segment dominated the market with a market share of 51.3% in 2023. The growth is attributed to the rapid advancements in healthcare infrastructure and expanding public-private partnerships. The home care settings segment is anticipated to showcase fastest growth at a CAGR 20.3% from 2024 to 2030

• In 2023, North America held the largest revenue share of 45.1%, due to its developed healthcare infrastructure and adoption of advanced medical devices. However, Asia Pacific is projected to experience the fastest growth at a CAGR of 21.2%, driven by increasing adoption of digital medical devices and rising awareness of smart inhaler benefits in the region

Smart Inhalers Market Segmentation

Grand View Research has segmented the global smart inhalers market based on type, indication, distribution channel, end use and region:

Smart Inhalers Type Outlook (Revenue, USD Million, 2018 - 2030)

• Dry Powdered Inhalers (DPIs)

• Metered Dose Inhalers (MDIs)

Smart Inhalers Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Asthma

• COPD

• Others

Smart Inhalers Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Smart Inhalers End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Homecare Settings

• Others

Smart Inhalers Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Russia

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Singapore

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

List Of Key Players Of Smart Inhalers Market

• Presspart Verwaltungs GmbH.

• Personal Air Quality Systems Pvt Ltd

• COHERO Health Inc. (AptarGroup, Inc.)

• Cognita Labs

• adherium

• Amiko Digital Health Limited.

• Teva Pharmaceuticals Industries Ltd.

• Propeller Health (ResMed)

• Novartis AG

• Pneuma Respiratory Inc.

• 3M

• AireHealth, Inc.

• FindAir Sp. z o.o